PAM2L
China,TNGlobal Q&A and Interviews,Biotech / MedTech,Features
Shenzhen-based PAM2L Biotechnologies plans new round of funding to expand capabilities
PAM2L Biotechnologies is one of the finalists of Fund At First Pitch at BEYOND Expo 2024.
August 30, 2024
Firmus scraps A$7 billion Australian IPO
October 9, 2026
TSMC quarterly revenue hits record NT$1.49 trillion
October 9, 2026
Indosat and F5 launch governed AI platform
October 9, 2026
Firmus scraps A$7 billion Australian IPO
October 9, 2026
TSMC quarterly revenue hits record NT$1.49 trillion
October 9, 2026
Indosat and F5 launch governed AI platform
October 9, 2026




